522 related articles for article (PubMed ID: 17936705)
1. Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation.
Kuyumcu-Martinez NM; Wang GS; Cooper TA
Mol Cell; 2007 Oct; 28(1):68-78. PubMed ID: 17936705
[TBL] [Abstract][Full Text] [Related]
2. Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy.
Wang GS; Kearney DL; De Biasi M; Taffet G; Cooper TA
J Clin Invest; 2007 Oct; 117(10):2802-11. PubMed ID: 17823658
[TBL] [Abstract][Full Text] [Related]
3. CUGBP1 overexpression in mouse skeletal muscle reproduces features of myotonic dystrophy type 1.
Ward AJ; Rimer M; Killian JM; Dowling JJ; Cooper TA
Hum Mol Genet; 2010 Sep; 19(18):3614-22. PubMed ID: 20603324
[TBL] [Abstract][Full Text] [Related]
4. PKC inhibition ameliorates the cardiac phenotype in a mouse model of myotonic dystrophy type 1.
Wang GS; Kuyumcu-Martinez MN; Sarma S; Mathur N; Wehrens XH; Cooper TA
J Clin Invest; 2009 Dec; 119(12):3797-806. PubMed ID: 19907076
[TBL] [Abstract][Full Text] [Related]
5. Expanded CTG repeats within the DMPK 3' UTR causes severe skeletal muscle wasting in an inducible mouse model for myotonic dystrophy.
Orengo JP; Chambon P; Metzger D; Mosier DR; Snipes GJ; Cooper TA
Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2646-51. PubMed ID: 18272483
[TBL] [Abstract][Full Text] [Related]
6. Correction of RNA-Binding Protein CUGBP1 and GSK3β Signaling as Therapeutic Approach for Congenital and Adult Myotonic Dystrophy Type 1.
Timchenko L
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31877772
[TBL] [Abstract][Full Text] [Related]
7. Heart-specific overexpression of CUGBP1 reproduces functional and molecular abnormalities of myotonic dystrophy type 1.
Koshelev M; Sarma S; Price RE; Wehrens XH; Cooper TA
Hum Mol Genet; 2010 Mar; 19(6):1066-75. PubMed ID: 20051426
[TBL] [Abstract][Full Text] [Related]
8. The RNA-binding protein CUGBP1 regulates stability of tumor necrosis factor mRNA in muscle cells: implications for myotonic dystrophy.
Zhang L; Lee JE; Wilusz J; Wilusz CJ
J Biol Chem; 2008 Aug; 283(33):22457-63. PubMed ID: 18559347
[TBL] [Abstract][Full Text] [Related]
9. Correction of Glycogen Synthase Kinase 3β in Myotonic Dystrophy 1 Reduces the Mutant RNA and Improves Postnatal Survival of DMSXL Mice.
Wang M; Weng WC; Stock L; Lindquist D; Martinez A; Gourdon G; Timchenko N; Snape M; Timchenko L
Mol Cell Biol; 2019 Nov; 39(21):. PubMed ID: 31383751
[TBL] [Abstract][Full Text] [Related]
10. Small molecule kinase inhibitors alleviate different molecular features of myotonic dystrophy type 1.
Wojciechowska M; Taylor K; Sobczak K; Napierala M; Krzyzosiak WJ
RNA Biol; 2014; 11(6):742-54. PubMed ID: 24824895
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic CUG RNA foci are insufficient to elicit key DM1 features.
Dansithong W; Wolf CM; Sarkar P; Paul S; Chiang A; Holt I; Morris GE; Branco D; Sherwood MC; Comai L; Berul CI; Reddy S
PLoS One; 2008; 3(12):e3968. PubMed ID: 19092997
[TBL] [Abstract][Full Text] [Related]
12. Ectopic expression of cyclin D3 corrects differentiation of DM1 myoblasts through activation of RNA CUG-binding protein, CUGBP1.
Salisbury E; Sakai K; Schoser B; Huichalaf C; Schneider-Gold C; Nguyen H; Wang GL; Albrecht JH; Timchenko LT
Exp Cell Res; 2008 Jul; 314(11-12):2266-78. PubMed ID: 18570922
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of CUG triplet repeat-binding protein, CUGBP1, in mice inhibits myogenesis.
Timchenko NA; Patel R; Iakova P; Cai ZJ; Quan L; Timchenko LT
J Biol Chem; 2004 Mar; 279(13):13129-39. PubMed ID: 14722059
[TBL] [Abstract][Full Text] [Related]
14. MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1.
de Haro M; Al-Ramahi I; De Gouyon B; Ukani L; Rosa A; Faustino NA; Ashizawa T; Cooper TA; Botas J
Hum Mol Genet; 2006 Jul; 15(13):2138-45. PubMed ID: 16723374
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic mechanisms of myotonic dystrophy.
Lee JE; Cooper TA
Biochem Soc Trans; 2009 Dec; 37(Pt 6):1281-6. PubMed ID: 19909263
[TBL] [Abstract][Full Text] [Related]
16. In vivo co-localisation of MBNL protein with DMPK expanded-repeat transcripts.
Fardaei M; Larkin K; Brook JD; Hamshere MG
Nucleic Acids Res; 2001 Jul; 29(13):2766-71. PubMed ID: 11433021
[TBL] [Abstract][Full Text] [Related]
17. Altered phosphorylation and intracellular distribution of a (CUG)n triplet repeat RNA-binding protein in patients with myotonic dystrophy and in myotonin protein kinase knockout mice.
Roberts R; Timchenko NA; Miller JW; Reddy S; Caskey CT; Swanson MS; Timchenko LT
Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13221-6. PubMed ID: 9371827
[TBL] [Abstract][Full Text] [Related]
18. Age of onset of RNA toxicity influences phenotypic severity: evidence from an inducible mouse model of myotonic dystrophy (DM1).
Gladman JT; Mandal M; Srinivasan V; Mahadevan MS
PLoS One; 2013; 8(9):e72907. PubMed ID: 24039817
[TBL] [Abstract][Full Text] [Related]
19. Celf1 regulates cell cycle and is partially responsible for defective myoblast differentiation in myotonic dystrophy RNA toxicity.
Peng X; Shen X; Chen X; Liang R; Azares AR; Liu Y
Biochim Biophys Acta; 2015 Jul; 1852(7):1490-7. PubMed ID: 25887157
[TBL] [Abstract][Full Text] [Related]
20. Sense and Antisense DMPK RNA Foci Accumulate in DM1 Tissues during Development.
Michel L; Huguet-Lachon A; Gourdon G
PLoS One; 2015; 10(9):e0137620. PubMed ID: 26339785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
